Helen Louise Collins

ELVN

Helen Louise Collins serves as officer: CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

14 trades

$7.28M

Net Position

Net Seller

$7.28M

Companies Traded

ELVN

Active Period

Apr 2024 – Oct 2026

14 total trades

Most Recent

Sell ELVN

Oct 21, 2026 · $192.3K

Helen Louise Collins's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

0 · $0.00

Sells

14 · $7.28M

Total Shares Bought

Total Shares Sold

230,816

ELVN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 21, 2026	Sell	5,000	$38.47	$192.3K	25,000
Sep 21, 2026	Sell	5,000	$50.35	$251.8K	27,084
Aug 19, 2026	Sell	5,000	$58.59	$292.9K	26,100
Jul 21, 2026	Sell	5,000	$52.67	$263.4K	29,769
Jun 22, 2026	Sell	5,000	$43.80	$219.0K	28,732
May 20, 2026	Sell	5,000	$39.79	$199.0K	26,525
Apr 21, 2026	Sell	5,000	$47.67	$238.4K	29,860
Mar 27, 2026	Sell	40,000	$35.10	$1.40M	25,000
Mar 19, 2026	Sell	5,000	$27.76	$138.8K	25,000
Mar 11, 2026	Sell	40,000	$30.07	$1.20M	25,000
Feb 19, 2026	Sell	45,000	$26.17	$1.18M	25,000
Feb 17, 2026	Sell	45,000	$26.17	$1.18M	0
Oct 18, 2024	Sell	816	$30.00	$24.5K	0
Apr 11, 2024	Sell	20,000	$25.07	$501.5K	0